Chen Wang

Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinib

Meng-Jun Tang, Yaowen Zhang, Zhanchun Zhang, 2021, Lipids in Health and Disease.

High expression of RASAL1, a hub gene in the progression of liver cancer, suggests a poor prognostis.

Liang Zhao, Jieqiong Lin, Juan Yi, 2022, American journal of translational research.

An artificial intelligence method to assess the tumor microenvironment with treatment outcomes for gastric cancer patients after gastrectomy

E. Guo, Guoxin Li, Wei Liang, 2022, Journal of Translational Medicine.

Inflammation‐based prognostic scoring system for predicting the prognosis of advanced small cell lung cancer patients receiving anlotinib monotherapy

Zhen-fei Xiang, W. Shen, Meng-Jun Tang, 2022, Journal of clinical laboratory analysis.

Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Their Variations as a Basis for a Prediction Model in Advanced NSCLC Patients Receiving Anlotinib

Meng-Jun Tang, Gaofeng Liang, Zhanchun Zhang, 2022, Disease markers.

Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus

Tianwu Chen, Yunyun Lu, Meng-Jun Tang, 2021, Cancer management and research.

Development and validation of a novel T cell proliferation-related prognostic model for predicting survival and immunotherapy benefits in melanoma

Xuan Zhang, Huabing Zhang, Rui Sun, 2023, Aging.

Pretreatment Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors and Reference Markers of Treatment Options for Locally Advanced Squamous Cell Carcinoma Located in the Middle and Upper Esophagus

Tianwu Chen, Yunyun Lu, Meng-Jun Tang, 2021 .